Outcome Measures in Polymyalgia Rheumatica. A Systematic Review

Cátia Duarte1, Ricardo Jorge de Oliveira Ferreira2, Sarah Louise Mackie2

  • 1From the Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra; Faculdade de Medicina, Universidade de Coimbra, Coimbra; and Health Sciences Research Unit: Nursing (UICISA:E), Coimbra, Portugal; Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, UK; and Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol, UK.C. Duarte, MD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, EPE; and Faculdade de Medicina, Universidade de Coimbra; R.J.O. Ferreira, RN, MSc, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, EPE; and Health Sciences Research Unit: Nursing (UICISA:E); S.L. Mackie, BM, BCh, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds; J.R. Kirwan, PhD, University of Bristol, Academic Rheumatology Unit, Bristol Royal Infirmary; J.A. Pereira da Silva, PhD, Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, EPE; and Faculdade de Medicina, Universidade de Coimbra. catiacmduarte@gmail.com.

The Journal of Rheumatology
|November 17, 2015
PubMed
Summary

This review found many different ways to measure polymyalgia rheumatica (PMR) outcomes in studies. A standardized set of validated outcome measures for PMR is needed.